Compare HGV & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HGV | AMRX |
|---|---|---|
| Founded | 1992 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.7B |
| IPO Year | 2017 | 2018 |
| Metric | HGV | AMRX |
|---|---|---|
| Price | $47.56 | $13.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $51.50 | $14.75 |
| AVG Volume (30 Days) | 675.5K | ★ 1.4M |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 97.78 | ★ 157.89 |
| EPS | ★ 0.89 | 0.22 |
| Revenue | ★ $5,047,000,000.00 | N/A |
| Revenue This Year | $24.95 | $4.48 |
| Revenue Next Year | $1.83 | $7.13 |
| P/E Ratio | ★ $52.28 | $58.41 |
| Revenue Growth | ★ 1.33 | N/A |
| 52 Week Low | $31.94 | $7.01 |
| 52 Week High | $52.08 | $15.42 |
| Indicator | HGV | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 67.85 | 57.19 |
| Support Level | $41.93 | $12.50 |
| Resistance Level | $48.98 | $13.54 |
| Average True Range (ATR) | 1.63 | 0.33 |
| MACD | 1.01 | 0.15 |
| Stochastic Oscillator | 98.13 | 92.09 |
Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts and timeshare plans under the Hilton Grand Vacations brand. The company operates in two segments: Real estate sales and financing, and Resort operations and club management. The Real estate sales and financing segment generates revenue from VOI sales and consumer financing, including interest income from loans to members. The Resort operations and club management segment generates revenue from resort management services, club membership fees, and rental of available inventory. The majority of the company's revenue is earned through the Real estate sales and financing segment.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.